Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Agent orange exposure and prostate cancer risk in the million veteran program.
Pagadala MS, Lui AJ, Zhong AY, Lynch JA, Karunamuni R, Lee KM, Plym A, Rose BS, Carter HK, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. Pagadala MS, et al. Among authors: lui aj. Acta Oncol. 2024 May 23;63:373-378. doi: 10.2340/1651-226X.2024.25053. Acta Oncol. 2024. PMID: 38779869 Free article.
The Evolving Landscape of B Cells in Cancer Metastasis.
Ramos MJ, Lui AJ, Hollern DP. Ramos MJ, et al. Among authors: lui aj. Cancer Res. 2023 Dec 1;83(23):3835-3845. doi: 10.1158/0008-5472.CAN-23-0620. Cancer Res. 2023. PMID: 37815800 Review.
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: lui ajw. Nat Cancer. 2023 Oct;4(10):1526. doi: 10.1038/s43018-023-00663-3. Nat Cancer. 2023. PMID: 37814012 Free PMC article. No abstract available.
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: lui ajw. Nat Cancer. 2023 Sep;4(9):1345-1361. doi: 10.1038/s43018-023-00630-y. Epub 2023 Sep 21. Nat Cancer. 2023. PMID: 37743366 Free PMC article.
ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging.
Lui AJ, Kallis K, Zhong AY, Hussain TS, Conlin C, Digma LA, Phan N, Mathews IT, Do DD, Domingo MR, Karunamuni R, Kuperman J, Dale AM, Shabaik A, Rakow-Penner R, Hahn ME, Seibert TM. Lui AJ, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1145-1152. doi: 10.1016/j.ijrobp.2023.07.004. Epub 2023 Jul 14. Int J Radiat Oncol Biol Phys. 2023. PMID: 37453559
Agent Orange exposure and prostate cancer risk in the Million Veteran Program.
Lui AJ, Pagadala MS, Zhong AY, Lynch J, Karunamuni R, Lee KM, Plym A, Rose BS, Carter H, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. Lui AJ, et al. medRxiv [Preprint]. 2023 Jun 16:2023.06.14.23291413. doi: 10.1101/2023.06.14.23291413. medRxiv. 2023. PMID: 37398205 Free PMC article. Preprint.
Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging.
Zhong AY, Digma LA, Hussain T, Feng CH, Conlin CC, Tye K, Lui AJ, Andreassen MMS, Rodríguez-Soto AE, Karunamuni R, Kuperman J, Kane CJ, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. Zhong AY, et al. Among authors: lui aj. Eur Urol Open Sci. 2022 Dec 15;47:20-28. doi: 10.1016/j.euros.2022.11.009. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601040 Free PMC article.
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer.
Saddawi-Konefka R, Schokrpur S, Lui AJ, Gutkind JS. Saddawi-Konefka R, et al. Among authors: lui aj. Cancer J. 2022 Sep-Oct 01;28(5):339-345. doi: 10.1097/PPO.0000000000000622. Cancer J. 2022. PMID: 36165721 Free PMC article. Review.
23 results